U.S. stocks plunged Friday, with major indexes hitting seven-month lows as a Middle East war continued to suppress risk appetite. The Dow entered correction territory, down over 10% from its record high. Rising oil prices fueled inflation fears, dampening hopes for Fed rate cuts.
Ajanta Pharma, Sun Pharma poised to tap GLP-1 opportunity amid market shift: Siddhartha Khemka
India’s metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging